LSD therapies and hallucinogenic mushrooms, neurotropic, formerly controversial, have a renewed interest among doctors. These substances, formerly associated with counter-culture, are today studied for their therapeutic potentials.
History and context of psychedelic therapies
The LSD, or diethylamide of lysergic acid, was synthesized for the first time in 1938 by the Swiss chemist Albert Hofmann. Initially studied for its effects on the central nervous system, it quickly attracted attention to its hallucinogenic properties.
Psilocybin and hallucinogenic mushrooms
There psilocybin, the active compound of hallucinogenic mushrooms has a long story of use in shamanic and spiritual rites. Discovered by the native peoples of Central America, it is today studied for its potential therapeutic effects.
The return to grace of psychedelics in modern medicine
After decades of prohibition, substances psychedelic As the LSD and Psilocybin make a return in force in the medical field. Recent studies show their effectiveness in the treatment of various psychiatric disorders.
Therapeutic advantages of LSD and psilocybin
Psychedelics offer significant therapeutic advantages, including rapid and lasting efficiency, and good tolerance in patients. They are particularly promising for conventional treatment patients.
Clinical studies and current research
Many clinical studies are underway to assess the efficiency and safety of therapies at LSD and psilocybine. In France, a Pioneer experience are led by the Nîmes University Hospital by experts like Dr Amandine Luquiens, addictologist psychiatrist.
Medical applications of LSD and fungi therapies
-
Resistant depression treatment | Psychedelics are used to treat the resistant depression to traditional treatments. Studies show that psilocybin can significantly improve the condition of depressed patients.
-
Addiction treatment | LSD and psilocybin are also used to treat addictions, especially at thealcohol. Research programs, such as that of Créteil's CHU Henri-Mondor, explore their potential to reduce relapse rates.
-
Support at the end of life | Psychedelic therapies are used to support Patients at the end of life, by reducing anxiety and improving the quality of life. In Switzerland, exceptional treatments are allowed for these patients.
Progress of psychedelic therapies
Before the first session, patients go through several evaluation and preparation interviews. These steps are crucial to ensure the safety and efficiency of treatment.
Therapy sessions
The day of the session, the environment (Set and Setting) is essential, patients take psychedelic substance under medical supervision. They are then placed in a controlled environment to live their psychedelic experience, which can last from six to twelve hours.
Risks and precautions related to psychedelic therapies
The medical supervision is essential to minimize the risks and maximize the profits of psychedelic therapies. Patients should be permanently monitored to manage the potential effects of the substance.
To read | Overdose of psychedelic magic mushrooms?
Ethical and legal challenges
Psychedelic therapies pose ethical and legal challenges, in particular with regard to regulations and social acceptance. Doctors must navigate these complexities to provide safe and effective treatments.
Conclusion
Therapies with LSD and hallucinogenic fungi represent a revolution in psychiatric medicine. Although challenges remain, their therapeutic potential is immense and continues to arouse the interest of researchers and doctors.
Faqs
1. What is the LSD?** The LSD is a hallucinogenic substance synthesized for the first time in 1938.
2. What is psilocybin?** Psilocybin is the active compound of hallucinogenic mushrooms.
3. What are the advantages of psychedelic therapies?** They offer rapid and lasting efficiency, and are well tolerated by patients.
4. What are the risks of psychedelic therapies?** Risks include intense emotional experiences, requiring strict medical supervision.
5. Where are research on psychedelic therapies?** Many clinical studies are underway to assess their efficiency and safety.
Quotes: [1] https://www.blick.ch/fr/news/suisse/la-confederation-veut-durcer-les-regles-les--herapies-au-lsd-et-champignons-toujoujou-populaires -Che-Medecins-ID19912855.html [2] https://www.polytechnique-insights.com/tribunes/sante-et-biotech/comment-le-lsd-et-la-mdma-soignent-les-troubles-psychiatrics/ [3] https://vih.org/drogues-et-rdr/20240122/la-france-et-la-medecine-psychedelique-une-histoire-complée/
Warning :
All the information contained in this article is based on sources and references, and all the opinions expressed are mine. I do not give advice to anyone and although I am happy to discuss subjects, if someone has another question or concern, he should ask for advice from a competent specialist. People who suffer from psychiatric, neurological or cardiovascular disorders or who use psychiatric drugs should completely avoid psychedelic and other drugs. Fabien de CBDTECH
